Cowen and Company’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History

Cowen and Company’s Portfolio DCPH Stock Details DCPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-1,292	Closed	-$44K	–	791
2021 Q3	$44K	Buy	+1,292	New	+$41.2K	﹤0.01%	398
2021 Q2	–	Sell	-8,109	Closed	-$314K	–	729
2021 Q1	$364K	Buy	+8,109	New	+$378K	0.03%	216

Other funds holding DCPH

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

NLVP

New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Cowen and Company's DCPH Position: Q4 2021 in Review

Cowen and Company sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q4 2021, closing a stake of 1,292 shares — an estimated $44K sold.

Cowen and Company first reported a position in DCPH in Q1 2021 and held it in 2 quarters. The position peaked at $364K in Q1 2021. 140 funds tracked by Wall St. Rank hold DCPH as of Q4 2021.

Cowen and Company reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
Cowen and Company sold 1,292 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q4 2021, an estimated $44K.
Cowen and Company first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q1 2021 and held it in 2 quarters.
Cowen and Company's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $364K in Q1 2021.
140 funds tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q4 2021.

Based on Cowen and Company's 13F filing for Q4 2021, filed 14 Feb 2022.